The US Chronicle of Philanthropy has written an article entitled “Controversy Over Drug Values at Aid Groups: A Look at a Key Player” – it has some discussion on valuation schemes in the Canadian context.

Here is the Chronicle of Philanthropy Article:  http://philanthropy.com/article/Controversy-Over-Drug-Values/129777/